Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1815073rdf:typepubmed:Citationlld:pubmed
pubmed-article:1815073lifeskim:mentionsumls-concept:C0026549lld:lifeskim
pubmed-article:1815073lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1815073lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1815073lifeskim:mentionsumls-concept:C1373180lld:lifeskim
pubmed-article:1815073pubmed:issue12lld:pubmed
pubmed-article:1815073pubmed:dateCreated1992-6-22lld:pubmed
pubmed-article:1815073pubmed:abstractTextMorphine (2.5 mg/kg) was administered iv to intact (I), bile duct-cannulated (BC), and bile duct-cannulated--renal-ligated (BC-RL) rats (n = 4 per group) to investigate the extent of enterohepatic recirculation and renal metabolism of the drug. A decrease in the serum area under the concentration-time curve (AUC) was observed for the BC in comparison with I rats. From these AUC values, it was determined that approximately 16% of the administered dose was subject to enterohepatic recirculation. In addition, a statistically significant (p less than 0.05) decrease in the systemic clearance of morphine was observed in the BC-RL rats compared with the BC animals (55.2 +/- 17.2 versus 31.4 +/- 8.5 mL/min/kg). This decrement in systemic clearance appeared to be the result of a significant decrease in the formation clearance of morphine glucuronide after ligation of the renal pedicles (23.2 +/- 4.8 versus 10.9 +/- 5.0 mL/min/kg). Renal metabolic clearance was calculated as 15.7 mL/min/kg, accounting for 28.5% of the systemic clearance of morphine. Hepatic clearance (31.4 +/- 8.5 mL/min/kg) accounted for 56.8% of total systemic clearance.lld:pubmed
pubmed-article:1815073pubmed:languageenglld:pubmed
pubmed-article:1815073pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1815073pubmed:citationSubsetIMlld:pubmed
pubmed-article:1815073pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1815073pubmed:statusMEDLINElld:pubmed
pubmed-article:1815073pubmed:monthDeclld:pubmed
pubmed-article:1815073pubmed:issn0022-3549lld:pubmed
pubmed-article:1815073pubmed:authorpubmed-author:HortonT LTLlld:pubmed
pubmed-article:1815073pubmed:authorpubmed-author:PollackG MGMlld:pubmed
pubmed-article:1815073pubmed:issnTypePrintlld:pubmed
pubmed-article:1815073pubmed:volume80lld:pubmed
pubmed-article:1815073pubmed:ownerNLMlld:pubmed
pubmed-article:1815073pubmed:authorsCompleteYlld:pubmed
pubmed-article:1815073pubmed:pagination1147-52lld:pubmed
pubmed-article:1815073pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:meshHeadingpubmed-meshheading:1815073-...lld:pubmed
pubmed-article:1815073pubmed:year1991lld:pubmed
pubmed-article:1815073pubmed:articleTitleEnterohepatic recirculation and renal metabolism of morphine in the rat.lld:pubmed
pubmed-article:1815073pubmed:affiliationDivision of Pharmaceutics, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.lld:pubmed
pubmed-article:1815073pubmed:publicationTypeJournal Articlelld:pubmed